Suchergebnisse - "Tsao, Anne"

PubPharm (190)

1

Pegargiminase Plus First-Line Chemotherapy in Patients With Nonepithelioid Pleural Mesothelioma : The ATOMIC-Meso Randomized Clinical Trial

enthalten in: JAMA oncology | 2024

von Szlosarek, P. | Creelan, B. | Sarkodie, T. | +42

2

Navigating professionalism challenges : Impact on patient safety

enthalten in: Journal of clinical anesthesia | 2024

von Wright, C. | Tsao, A. | Triller, M. | +1

3

Real-World Efficacy and Safety of Amivantamab for EGFR-Mutant NSCLC

enthalten in: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer | 2024

von Wang, K. | Du, R. | Myall, N. | +24

4

A plain language summary of the PHAROS study : the combination of encorafenib and binimetinib for people with BRAF V600E-mutant metastatic non-small cell lung cancer

enthalten in: Future oncology (London, England) | 2024

von Riely, G. | Smit, E. | Ahn, M. | +22

5

Brief Report : Comprehensive Clinicogenomic Profiling of Small Cell Transformation From EGFR-Mutant NSCLC Informs Potential Therapeutic Targets

enthalten in: JTO clinical and research reports | 2024

von Zhang, B. | Lewis, W. | Stewart, C. | +33

6

Stereotactic ablative radiotherapy with or without immunotherapy for early-stage or isolated lung parenchymal recurrent node-negative non-small-cell lung cancer : an open-label, randomised, phase 2 trial

enthalten in: Lancet (London, England) | 2023

von Chang, J. | Lin, S. | Dong, W. | +25

CommentIn: Lancet. 2023 Sep 9;402(10405):829-831. - PMID 37478884

7

Brief Report : Clinical Response, Toxicity, and Resistance Mechanisms to Osimertinib Plus MET Inhibitors in Patients With EGFR-Mutant MET-Amplified NSCLC

enthalten in: JTO clinical and research reports | 2023

von Wang, K. | Du, R. | Roy-Chowdhuri, S. | +22

8

Tumor thickness in mesothelioma predicts differential response to neoadjuvant therapy and survival

enthalten in: The Journal of thoracic and cardiovascular surgery | 2023

von Zhou, N. | Bell, C. | Feldman, H. | +14

CommentIn: J Thorac Cardiovasc Surg. 2023 Aug;166(2):372-373. - PMID 36732146

9

Phase II, Open-Label Study of Encorafenib Plus Binimetinib in Patients With BRAFV600-Mutant Metastatic Non-Small-Cell Lung Cancer

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2023

von Riely, G. | Smit, E. | Ahn, M. | +22

CommentIn: J Clin Oncol. 2023 Jul 20;41(21):3679-3681. - PMID 37270690

10

Vidutolimod in Combination With Atezolizumab With and Without Radiation Therapy in Patients With Programmed Cell Death Protein 1 or Programmed Death-Ligand 1 Blockade-Resistant Advanced NSCLC

enthalten in: JTO clinical and research reports | 2023

von Negrao, M. | Papadimitrakopoulou, V. | Price, A. | +14

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[19]